Physician profile
Joseph Cutrone
NPI 1790218238
$2,333.46
in general payments reported to CMS, 2019-2025
12 companies · $14.60 in 2025
The $14.60 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $371 · 2020: $146 · 2021: $59.41 · 2022: $1,319 · 2023: $235 · 2024: $189 · 2025: $14.60.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $438.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $438.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,822.79 | 2019-2024 | |
| Abbvie INC. | $143.46 | 2022-2023 | Botox |
| Otsuka America Pharmaceutical, INC. | $126.93 | 2023-2024 | Jynarque |
| Bayer Healthcare Pharmaceuticals INC. | $89.45 | 2024 | |
| Glaxosmithkline, LLC. | $24.35 | 2023 | Benlysta |
| Myovant Sciences INC. | $24.02 | 2021 | |
| Axonics, INC. | $23.97 | 2024 | Axonics |
| Pfizer INC. | $18.05 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.31 | 2024 | Jardiance |
| C. R. Bard, INC. & Subsidiaries | $14.60 | 2025 | Proxis Ureteral Access Sheath |
| Merck Sharp & Dohme LLC | $14.55 | 2022 | |
| Sumitomo Pharma America, INC. | $13.98 | 2023 | Gemtesa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Cutrone listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.